Target intelligence / Profile preview

RN7SK pseudogene 161 (RN7SKP161)

Target
RN7SKP161
Molecular classification
Other (Pseudogene)
01

Overview

RN7SK pseudogene 161 (RN7SKP161) is a human genomic pseudogene annotated as a non-coding sequence similar to the functional 7SK small nuclear RNA gene, but lacking the capacity to encode a functional RNA or protein. Pseudogenes are generally transcriptionally inactive and do not participate in cellular processes attributed to their functional counterparts. While the parental RN7SK is an important regulator in transcriptional elongation by RNA polymerase II and implicated in diseases such as HIV infection and immune deficiency[1][5], RN7SK pseudogene 161 itself has no documented biological function, therapeutic relevance, or drug interaction, and should not be regarded as a therapeutic target[3][2][6].

Other names
RN7SKP161RNA, 7SK small nuclear pseudogene 161
02

Mechanism of action

None. There is no known mechanism for any drug targeting RN7SKP161

03

Biological functions

None established for the pseudogene itself. Functional RN7SK (not RN7SKP161) is a non-coding RNA involved in transcriptional regulation
04

Disease associations

None established for RN7SKP161. Functional RN7SK has associations noted with diseases such as HIV infection and immunodeficiency, but not for the pseudogene variant
05

Safety considerations

None specific to RN7SKP161. As it is a pseudogene and does not produce a functional product, it is not associated with therapeutic safety challenges
06

Interacting drugs

None. There are no documented drugs targeting this pseudogene
07

Biomarkers

None. RN7SKP161 is not used as a biomarker for patient selection or efficacy monitoring

Beyond the preview

Go deeper on RN7SK pseudogene 161 (RN7SKP161).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RN7SK pseudogene 161 (RN7SKP161).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call